FI951901A - Stabiili pidennysti vapautuva, oraalisesti annosteltava koostumus - Google Patents

Stabiili pidennysti vapautuva, oraalisesti annosteltava koostumus Download PDF

Info

Publication number
FI951901A
FI951901A FI951901A FI951901A FI951901A FI 951901 A FI951901 A FI 951901A FI 951901 A FI951901 A FI 951901A FI 951901 A FI951901 A FI 951901A FI 951901 A FI951901 A FI 951901A
Authority
FI
Finland
Prior art keywords
extended release
orally administrable
administrable composition
stable extended
film
Prior art date
Application number
FI951901A
Other languages
English (en)
Swedish (sv)
Other versions
FI112916B (fi
FI951901A0 (fi
Inventor
Henry K Kwan
Stephen M Liebowitz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI951901A publication Critical patent/FI951901A/fi
Publication of FI951901A0 publication Critical patent/FI951901A0/fi
Application granted granted Critical
Publication of FI112916B publication Critical patent/FI112916B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
FI951901A 1992-10-23 1995-04-21 Menetelmä kalvopäällystetyn pidennetysti vapauttavan, oraalisesti annosteltavan koostumuksen valmistamiseksi FI112916B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US96547092 1992-10-23
US07/965,470 US5314697A (en) 1992-10-23 1992-10-23 Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US9309873 1993-10-21
PCT/US1993/009873 WO1994009761A1 (en) 1992-10-23 1993-10-21 Stable extended release oral dosage composition

Publications (3)

Publication Number Publication Date
FI951901A true FI951901A (fi) 1995-04-21
FI951901A0 FI951901A0 (fi) 1995-04-21
FI112916B FI112916B (fi) 2004-02-13

Family

ID=25510010

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951901A FI112916B (fi) 1992-10-23 1995-04-21 Menetelmä kalvopäällystetyn pidennetysti vapauttavan, oraalisesti annosteltavan koostumuksen valmistamiseksi

Country Status (28)

Country Link
US (1) US5314697A (fi)
EP (1) EP0665744B1 (fi)
JP (1) JP3580815B2 (fi)
KR (1) KR100283709B1 (fi)
CN (1) CN1038474C (fi)
AT (1) ATE161420T1 (fi)
AU (1) AU676229B2 (fi)
CA (1) CA2147606C (fi)
CZ (1) CZ287687B6 (fi)
DE (1) DE69316023T2 (fi)
DK (1) DK0665744T3 (fi)
EE (1) EE03106B1 (fi)
ES (1) ES2110633T3 (fi)
FI (1) FI112916B (fi)
GR (1) GR3026198T3 (fi)
HK (1) HK1004327A1 (fi)
HU (1) HU220629B1 (fi)
IL (1) IL107354A (fi)
MY (1) MY109090A (fi)
NO (1) NO308771B1 (fi)
NZ (1) NZ257447A (fi)
PH (1) PH29940A (fi)
PL (1) PL172862B1 (fi)
SG (1) SG42947A1 (fi)
SK (1) SK281090B6 (fi)
TW (1) TW251239B (fi)
WO (1) WO1994009761A1 (fi)
ZA (1) ZA937830B (fi)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7966694A (en) * 1993-07-21 1996-05-02 University Of Kentucky Research Foundation, The A multicompartment hard capsule with control release properties
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US7211582B1 (en) 1994-12-30 2007-05-01 Sepracor Inc. Methods for treating urticaria using descarboethoxyloratadine
US7214683B1 (en) 1994-12-30 2007-05-08 Sepracor Inc. Compositions of descarboethoxyloratadine
HUP9802086A3 (en) * 1995-02-28 2001-02-28 Aventis Pharmaceuticals Inc Br Pharmaceutical composition for piperidinoalkanol compounds
US5807579A (en) * 1995-11-16 1998-09-15 F.H. Faulding & Co. Limited Pseudoephedrine combination pharmaceutical compositions
EP0811374A1 (en) 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
KR20000052922A (ko) * 1996-10-31 2000-08-25 둘락 노먼 씨. 로라타딘 및 충혈제거제를 함유하는 천식 치료용 조성물
TW522014B (en) * 1997-02-07 2003-03-01 Sepracor Inc Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
ID22891A (id) * 1997-08-26 1999-12-16 Hoechst Marion Roussel Inc Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
AU6018899A (en) * 1998-09-10 2000-04-03 Schering Corporation Antihistamines for treating non-infective sinusitis or otitis media
US6051585A (en) * 1998-12-07 2000-04-18 Weinstein; Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
CN1161112C (zh) * 1999-02-23 2004-08-11 株式会社柳韩洋行 含氯雷他定和伪麻黄碱的药物胶囊组合物
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6100274A (en) * 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US6267986B1 (en) 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
US6114346A (en) 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
SK287105B6 (sk) * 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
SK287684B6 (sk) * 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist
US7147870B2 (en) * 2000-01-13 2006-12-12 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
CA2405238C (en) * 2000-04-14 2014-03-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
US20020094345A1 (en) * 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
AU2002220248A1 (en) * 2000-11-06 2002-05-15 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
BR0210534A (pt) * 2001-06-20 2004-06-22 Schering Corp Anti-histaminas para o tratamento de congestão nasal e obstrução nasal
WO2004019917A1 (es) * 2002-08-29 2004-03-11 Osmotica Corp. Dispositivo de liberacion de droga que contiene oseltamivir y un antagonista h1
US6720002B2 (en) 2001-07-20 2004-04-13 R.P. Scherer Technologies, Inc. Antihistamine formulations for soft capsule dosage forms
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US20040051686A1 (en) * 2002-09-17 2004-03-18 Yuan-Sung Weng Carry-on device having functions of both digital photographing and timing
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
ATE544447T1 (de) 2003-09-26 2012-02-15 Alza Corp Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
US20050095288A1 (en) * 2003-11-03 2005-05-05 Andrx Labs, Llc Decongestant and expectorant tablets
WO2005053599A1 (ja) 2003-12-01 2005-06-16 Takeda Pharmaceutical Company Limited 固形製剤の印刷前処理方法及び印刷前処理方法が施された固形製剤
US20050266032A1 (en) * 2003-12-17 2005-12-01 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
SE0401031D0 (sv) 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
US20060024368A1 (en) * 2004-07-30 2006-02-02 Reza Fassihi Compressed composite delivery system for release-rate modulation of bioactives
KR20070095456A (ko) * 2005-01-27 2007-09-28 알렘빅 리미티드 레베티라세탐의 서방형 제제
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
US20070281020A1 (en) * 2006-06-01 2007-12-06 Ulloa Sergio R Pharmaceutical compositions for sustained release of phenylephrine
CN101015519B (zh) * 2007-02-27 2012-03-21 重庆医药工业研究院有限责任公司 一种氯雷他定口服复方药物组合物
WO2008105920A1 (en) * 2007-02-28 2008-09-04 Collegium Pharmaceutical, Inc. Antihistamine combination
AU2008359725A1 (en) * 2008-07-24 2010-01-28 Handa Pharmaceuticals, Llc Stabilized atypical antipsychotic formulation
EP3045043B1 (en) 2009-02-26 2020-04-29 Relmada Therapeutics, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
CA2690490C (en) 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
CN102160859B (zh) * 2011-02-23 2012-11-07 海南斯达制药有限公司 一种氯雷伪麻复方缓释药物
JP5752578B2 (ja) * 2011-12-09 2015-07-22 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
CN104983708A (zh) * 2015-06-24 2015-10-21 万特制药(海南)有限公司 一种地氯雷他定硫酸伪麻黄碱缓释片及其制备方法
CN108576895B (zh) * 2018-03-06 2021-04-30 特素生物科技（天津）有限公司 缓释营养主食及其制备方法
EP4188339A1 (en) 2020-07-30 2023-06-07 Faes Farma, S.A. Decongestant drug delivery system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282233B1 (en) * 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
US4601894A (en) * 1985-03-29 1986-07-22 Schering Corporation Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
IE60311B1 (en) * 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
CN1053570C (zh) * 1987-10-07 2000-06-21 默尔多药物公司 哌啶子基链烷醇的药用组合物-减充血剂复方的制备方法
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine

Also Published As

Publication number Publication date
PH29940A (en) 1996-09-16
EP0665744A1 (en) 1995-08-09
CA2147606A1 (en) 1994-05-11
SK52295A3 (en) 1997-05-07
CZ287687B6 (en) 2001-01-17
IL107354A (en) 1998-02-08
FI112916B (fi) 2004-02-13
DK0665744T3 (da) 1998-09-07
CZ101495A3 (en) 1996-02-14
CN1089471A (zh) 1994-07-20
CN1038474C (zh) 1998-05-27
EE03106B1 (et) 1998-08-17
AU5405094A (en) 1994-05-24
JPH08502516A (ja) 1996-03-19
IL107354A0 (en) 1994-01-25
EP0665744B1 (en) 1997-12-29
DE69316023D1 (de) 1998-02-05
HK1004327A1 (en) 1998-11-20
NO951527L (no) 1995-06-20
ATE161420T1 (de) 1998-01-15
NO308771B1 (no) 2000-10-30
CA2147606C (en) 2000-10-10
WO1994009761A1 (en) 1994-05-11
PL172862B1 (pl) 1997-12-31
MY109090A (en) 1996-11-30
AU676229B2 (en) 1997-03-06
JP3580815B2 (ja) 2004-10-27
SK281090B6 (sk) 2000-11-07
ZA937830B (en) 1994-04-21
FI951901A0 (fi) 1995-04-21
SG42947A1 (en) 1997-10-17
KR950703937A (ko) 1995-11-17
NO951527D0 (no) 1995-04-21
HU220629B1 (hu) 2002-03-28
TW251239B (fi) 1995-07-11
HU9501143D0 (en) 1995-06-28
US5314697A (en) 1994-05-24
HUT71682A (en) 1996-01-29
PL308491A1 (en) 1995-08-07
KR100283709B1 (ko) 2001-03-02
GR3026198T3 (en) 1998-05-29
ES2110633T3 (es) 1998-02-16
NZ257447A (en) 1996-09-25
DE69316023T2 (de) 1998-04-23

Similar Documents

Publication Publication Date Title
FI951901A (fi) Stabiili pidennysti vapautuva, oraalisesti annosteltava koostumus
ATE128355T1 (de) Mischungen gegen husten/erkältungen mit gehalt an nichtsedierenden antihistaminika.
US4552899B1 (fi)
CA2329217A1 (en) Stable extended release oral dosage composition comprising desloratadine and pseudoephedrine
MY126555A (en) Oral pharmaceutical extended release dosage form
ATE79549T1 (de) Nicht-sedative antihistaminica enthaltende husten-/schnupfenmittel.
MX9706769A (es) Formas de dosificacion farmaceutica que comprenden un inhibidor de la bomba de protones y un agente procinetico.
DE59406075D1 (de) Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreitsetzung
CO5031291A1 (es) Composicion farmaceutica
DE69516671D1 (de) Verbindungen mit analgetischem und lokalanesthetischem effekt
NO993921D0 (no) Medikament mot infertilitet og for ökt fertilitet
DE69026295D1 (de) Pharmazeutische Zusammensetzung gegen durch Vasokonstriktion hervorgerufene Krankheiten
JPS527567A (en) Apparatus for transferring medicines for individual patients
MX9205204A (es) Composicion farmaceutica que comprende compuestos antagonistas del receptor 5-hidroxitriptamina
JO1821B1 (en) New pharmaceutical product

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: MERCK SHARP & DOHME CORP.

MA Patent expired